APA

Savage D. A., Feeney S. A., Fogarty D. G. & Maxwell A. P. (19990629). Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control. : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Chicago

Savage D A, Feeney S A, Fogarty D G and Maxwell A P. 19990629. Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control. : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Harvard

Savage D. A., Feeney S. A., Fogarty D. G. and Maxwell A. P. (19990629). Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control. : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

MLA

Savage D A, Feeney S A, Fogarty D G and Maxwell A P. Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control. : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 19990629.